SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K reports on the results of the 2021 Annual Meeting of Shareholders held on May 28, 2021, in Los Angeles, California. The registrant is Second Sight Medical Products, Inc. (Note: The request metadata referenced "Vivani Medical, Inc.", but the filing text explicitly identifies the company as Second Sight Medical Products, Inc.). A total of 17,017,775 shares were represented at the meeting, constituting a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
The following proposals were submitted to and voted upon by shareholders:
- Proposal 1 (Election of Directors): All six nominees were elected to the Board of Directors. Votes ranged from approximately 11.71 million to 11.73 million "For" votes, with abstentions ranging from 108,275 to 132,127. There were 5,174,792 broker non-votes for each nominee.
- Proposal 2 (Ratification of Auditors): Shareholders ratified the appointment of Gumbiner Savett Inc. as the independent registered public accounting firm for the year ending December 31, 2021. The vote was 16,790,398 "For", 142,622 "Against", and 84,755 "Abstentions".
- Proposal 3 (Executive Compensation): Shareholders ratified the compensation of named executive officers on a non-binding basis. The vote was 11,546,765 "For", 207,655 "Against", and 88,563 "Abstentions".
- Proposal 4 (Say-on-Pay Frequency): Shareholders indicated a preference for the frequency of advisory votes on executive compensation. The majority (11,651,980 votes) selected a 1-year frequency, compared to 102,607 for 2 years and 46,399 for 3 years.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. The document notes that a press release detailing the meeting results was issued on June 1, 2021, and is attached as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the correct company identity: The filing is for Second Sight Medical Products, Inc. (Ticker: EYES), not Vivani Medical, Inc.
- Confirm the election of the six specific director nominees: Gregg Williams, Aaron Mendelsohn, Jonathan Will McGuire, Matthew Pfeffer, Dean Baker, and Alexandra Larson.
- Note the significant number of broker non-votes (5,174,792) on director elections and executive compensation proposals.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the meeting not included in the 8-K text.